Matches in SemOpenAlex for { <https://semopenalex.org/work/W2799346871> ?p ?o ?g. }
- W2799346871 endingPage "9593" @default.
- W2799346871 startingPage "9580" @default.
- W2799346871 abstract "Many mutations in genes encoding proteins such as Parkin, PTEN-induced putative kinase 1 (PINK1), protein deglycase DJ-1 (DJ-1 or PARK7), leucine-rich repeat kinase 2 (LRRK2), and α-synuclein have been linked to familial forms of Parkinson's disease (PD). The consequences of these mutations, such as altered mitochondrial function and pathological protein aggregation, are starting to be better understood. However, little is known about the mechanisms explaining why alterations in such diverse cellular processes lead to the selective loss of dopamine (DA) neurons in the substantia nigra (SNc) in the brain of individuals with PD. Recent work has shown that one of the reasons for the high vulnerability of SNc DA neurons is their high basal rate of mitochondrial oxidative phosphorylation (OXPHOS), resulting from their highly complex axonal arborization. Here, we examined whether axonal growth and basal mitochondrial function are altered in SNc DA neurons from Parkin-, Pink1-, or DJ-1–KO mice. We provide evidence for increased basal OXPHOS in Parkin-KO DA neurons and for reduced survival of DA neurons that have a complex axonal arbor. The surviving smaller neurons exhibited reduced vulnerability to the DA neurotoxin and mitochondrial complex I inhibitor MPP+, and this reduction was associated with reduced expression of the DA transporter. Finally, we found that glial cells play a role in the reduced resilience of DA neurons in these mice and that WT Parkin overexpression rescues this phenotype. Our results provide critical insights into the complex relationship between mitochondrial function, axonal growth, and genetic risk factors for PD. Many mutations in genes encoding proteins such as Parkin, PTEN-induced putative kinase 1 (PINK1), protein deglycase DJ-1 (DJ-1 or PARK7), leucine-rich repeat kinase 2 (LRRK2), and α-synuclein have been linked to familial forms of Parkinson's disease (PD). The consequences of these mutations, such as altered mitochondrial function and pathological protein aggregation, are starting to be better understood. However, little is known about the mechanisms explaining why alterations in such diverse cellular processes lead to the selective loss of dopamine (DA) neurons in the substantia nigra (SNc) in the brain of individuals with PD. Recent work has shown that one of the reasons for the high vulnerability of SNc DA neurons is their high basal rate of mitochondrial oxidative phosphorylation (OXPHOS), resulting from their highly complex axonal arborization. Here, we examined whether axonal growth and basal mitochondrial function are altered in SNc DA neurons from Parkin-, Pink1-, or DJ-1–KO mice. We provide evidence for increased basal OXPHOS in Parkin-KO DA neurons and for reduced survival of DA neurons that have a complex axonal arbor. The surviving smaller neurons exhibited reduced vulnerability to the DA neurotoxin and mitochondrial complex I inhibitor MPP+, and this reduction was associated with reduced expression of the DA transporter. Finally, we found that glial cells play a role in the reduced resilience of DA neurons in these mice and that WT Parkin overexpression rescues this phenotype. Our results provide critical insights into the complex relationship between mitochondrial function, axonal growth, and genetic risk factors for PD." @default.
- W2799346871 created "2018-05-17" @default.
- W2799346871 creator A5007223620 @default.
- W2799346871 creator A5007730226 @default.
- W2799346871 creator A5024580674 @default.
- W2799346871 creator A5047357837 @default.
- W2799346871 creator A5052424005 @default.
- W2799346871 creator A5061833849 @default.
- W2799346871 creator A5065146020 @default.
- W2799346871 creator A5077466388 @default.
- W2799346871 creator A5079572294 @default.
- W2799346871 date "2018-06-01" @default.
- W2799346871 modified "2023-10-03" @default.
- W2799346871 title "Comparative analysis of Parkinson's disease–associated genes in mice reveals altered survival and bioenergetics of Parkin-deficient dopamine neurons" @default.
- W2799346871 cites W1518704304 @default.
- W2799346871 cites W1543452323 @default.
- W2799346871 cites W1588910430 @default.
- W2799346871 cites W1588992136 @default.
- W2799346871 cites W1698967089 @default.
- W2799346871 cites W1933870215 @default.
- W2799346871 cites W1957983000 @default.
- W2799346871 cites W1963577160 @default.
- W2799346871 cites W1975040149 @default.
- W2799346871 cites W1981128350 @default.
- W2799346871 cites W1981337996 @default.
- W2799346871 cites W1985399632 @default.
- W2799346871 cites W2002353885 @default.
- W2799346871 cites W2004736998 @default.
- W2799346871 cites W2010478595 @default.
- W2799346871 cites W2010914316 @default.
- W2799346871 cites W2016188701 @default.
- W2799346871 cites W2018133355 @default.
- W2799346871 cites W2032550684 @default.
- W2799346871 cites W2033927188 @default.
- W2799346871 cites W2033988038 @default.
- W2799346871 cites W2038557175 @default.
- W2799346871 cites W2045638118 @default.
- W2799346871 cites W2051484672 @default.
- W2799346871 cites W2054466443 @default.
- W2799346871 cites W2055124287 @default.
- W2799346871 cites W2059829246 @default.
- W2799346871 cites W2069008440 @default.
- W2799346871 cites W2073580150 @default.
- W2799346871 cites W2080929675 @default.
- W2799346871 cites W2089953140 @default.
- W2799346871 cites W2093370096 @default.
- W2799346871 cites W2112203605 @default.
- W2799346871 cites W2124300794 @default.
- W2799346871 cites W2128631317 @default.
- W2799346871 cites W2139425547 @default.
- W2799346871 cites W2140647923 @default.
- W2799346871 cites W2143367061 @default.
- W2799346871 cites W2145664571 @default.
- W2799346871 cites W2146446101 @default.
- W2799346871 cites W2149104679 @default.
- W2799346871 cites W2152817972 @default.
- W2799346871 cites W2158259597 @default.
- W2799346871 cites W2160681852 @default.
- W2799346871 cites W2163961975 @default.
- W2799346871 cites W2165128853 @default.
- W2799346871 cites W2171873547 @default.
- W2799346871 cites W2273029159 @default.
- W2799346871 cites W2580495962 @default.
- W2799346871 cites W2743006719 @default.
- W2799346871 cites W2783409125 @default.
- W2799346871 cites W623509592 @default.
- W2799346871 doi "https://doi.org/10.1074/jbc.ra117.000499" @default.
- W2799346871 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6016451" @default.
- W2799346871 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29700116" @default.
- W2799346871 hasPublicationYear "2018" @default.
- W2799346871 type Work @default.
- W2799346871 sameAs 2799346871 @default.
- W2799346871 citedByCount "29" @default.
- W2799346871 countsByYear W27993468712019 @default.
- W2799346871 countsByYear W27993468712020 @default.
- W2799346871 countsByYear W27993468712021 @default.
- W2799346871 countsByYear W27993468712022 @default.
- W2799346871 countsByYear W27993468712023 @default.
- W2799346871 crossrefType "journal-article" @default.
- W2799346871 hasAuthorship W2799346871A5007223620 @default.
- W2799346871 hasAuthorship W2799346871A5007730226 @default.
- W2799346871 hasAuthorship W2799346871A5024580674 @default.
- W2799346871 hasAuthorship W2799346871A5047357837 @default.
- W2799346871 hasAuthorship W2799346871A5052424005 @default.
- W2799346871 hasAuthorship W2799346871A5061833849 @default.
- W2799346871 hasAuthorship W2799346871A5065146020 @default.
- W2799346871 hasAuthorship W2799346871A5077466388 @default.
- W2799346871 hasAuthorship W2799346871A5079572294 @default.
- W2799346871 hasBestOaLocation W27993468711 @default.
- W2799346871 hasConcept C104317684 @default.
- W2799346871 hasConcept C126322002 @default.
- W2799346871 hasConcept C137183658 @default.
- W2799346871 hasConcept C169760540 @default.
- W2799346871 hasConcept C190283241 @default.
- W2799346871 hasConcept C203522944 @default.
- W2799346871 hasConcept C2776804853 @default.
- W2799346871 hasConcept C2776925932 @default.
- W2799346871 hasConcept C2777668072 @default.